Apollo Hospitals Enterprise Ltd

Apollo Hospitals Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Apollo Hospitals Enterprise Ltd

₹ 8,090 -0.23%
02 Jun - close price
apollohospitals.com BSE: 508869 NSE: APOLLOHOSP
About

Apollo Hospitals was established in 1983 by Dr. Prathap C Reddy, renowned architect of modern healthcare in India. As the nation’s first corporate hospital, Apollo Hospitals is acclaimed for pioneering the private healthcare revolution in the country.

Apollo Hospitals has emerged as Asia’s foremost integrated healthcare services provider and has a robust presence across the healthcare ecosystem, including Hospitals, Pharmacies,
Primary Care & Diagnostic Clinics and several Retail Health models. [1]

Key Points

Business Segments
1) Healthcare Services (50% in H1 FY26 vs 55% in FY22):[1][2][3]
The company has a capacity of 10,200 beds in 73 hospitals located in India and overseas, out of which 8,767 beds are located in 45 owned hospitals, 643 beds in Day Surgery & Cradles and 790 beds are in 6 hospitals under management through operations and management contracts.

Website BSE NSE
  • Market Cap ₹ 1,16,445 Cr.
  • Current Price ₹ 8,090
  • High / Low ₹ 8,490 / 6,680
  • Stock P/E 59.5
  • Book Value ₹ 659
  • Dividend Yield 0.23 %
  • ROCE 17.9 %
  • ROE 22.1 %
  • Face Value ₹ 5.00
Edit ratios

Pros

  • Company has delivered good profit growth of 77.8% CAGR over last 5 years
  • Company has been maintaining a healthy dividend payout of 17.7%

Cons

  • Stock is trading at 12.3 times its book value
  • Company might be capitalizing the interest cost

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of Nifty 50 BSE 500 BSE Healthcare BSE 100 BSE 200

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
4,302 4,418 4,847 4,851 4,944 5,086 5,589 5,527 5,592 5,842 6,304 6,477 6,606
3,814 3,909 4,219 4,237 4,303 4,410 4,774 4,765 4,822 4,990 5,362 5,512 5,594
Operating Profit 488 509 628 614 640 675 816 762 770 852 941 965 1,011
OPM % 11% 12% 13% 13% 13% 13% 15% 14% 14% 15% 15% 15% 15%
20 34 26 29 37 49 44 69 72 54 61 48 54
Interest 95 106 111 113 119 116 118 110 115 108 110 113 119
Depreciation 159 167 163 167 190 177 184 185 211 215 218 219 224
Profit before tax 254 270 379 363 368 430 557 536 516 583 675 682 722
Tax % 43% 36% 34% 30% 30% 27% 29% 29% 20% 24% 27% 24% 24%
146 173 249 254 258 316 396 379 414 441 494 516 551
EPS in Rs 10.05 11.59 16.20 17.06 17.65 21.23 26.34 25.89 27.10 30.10 33.19 34.93 36.81
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
5,129 6,150 7,256 8,243 9,617 11,247 10,560 14,663 16,612 19,059 21,794 25,228
4,392 5,465 6,522 7,442 8,548 9,656 9,420 12,474 14,548 16,665 18,761 21,459
Operating Profit 737 684 734 801 1,070 1,591 1,140 2,189 2,065 2,394 3,033 3,769
OPM % 14% 11% 10% 10% 11% 14% 11% 15% 12% 13% 14% 15%
47 92 60 24 26 222 103 368 75 123 222 217
Interest 118 180 257 295 327 533 449 379 381 449 458 450
Depreciation 212 264 314 359 396 620 573 601 615 687 758 876
Profit before tax 455 332 222 171 373 660 221 1,578 1,144 1,380 2,039 2,661
Tax % 29% 29% 41% 65% 47% 34% 38% 30% 22% 32% 26% 25%
335 235 131 60 200 432 137 1,108 844 935 1,505 2,003
EPS in Rs 24.43 16.99 15.88 8.44 16.96 32.70 10.46 73.42 56.97 62.50 100.56 135.04
Dividend Payout % 24% 35% 38% 59% 35% 18% 29% 16% 26% 26% 13% 15%
Compounded Sales Growth
10 Years: 15%
5 Years: 19%
3 Years: 15%
TTM: 16%
Compounded Profit Growth
10 Years: 24%
5 Years: 78%
3 Years: 34%
TTM: 40%
Stock Price CAGR
10 Years: 19%
5 Years: 19%
3 Years: 18%
1 Year: 17%
Return on Equity
10 Years: 13%
5 Years: 17%
3 Years: 18%
Last Year: 22%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 70 70 70 70 70 70 72 72 72 72 72 72
Reserves 3,102 3,262 3,244 3,182 3,264 3,270 4,531 5,551 6,126 6,864 8,140 9,408
1,992 2,834 3,125 3,427 3,673 3,596 4,160 4,068 4,332 5,333 7,864 8,493
1,296 1,195 1,665 1,917 2,159 4,354 2,629 3,570 3,886 4,474 4,568 4,224
Total Liabilities 6,459 7,360 8,103 8,596 9,166 11,289 11,392 13,261 14,416 16,742 20,644 22,197
3,244 3,997 4,591 4,773 4,982 7,432 6,778 8,296 8,520 9,664 10,988 12,312
CWIP 533 562 347 712 822 236 234 46 610 873 921 992
Investments 311 352 406 352 462 434 1,343 816 574 986 2,487 2,179
2,372 2,448 2,759 2,759 2,901 3,187 3,037 4,104 4,712 5,219 6,248 6,714
Total Assets 6,459 7,360 8,103 8,596 9,166 11,289 11,392 13,261 14,416 16,742 20,644 22,197

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
470 597 623 537 905 1,293 1,265 1,696 1,377 1,920 2,136 2,856
-759 -888 -1,152 -405 -711 -289 -880 -747 -857 -1,537 -3,381 -2,148
392 330 477 -108 -215 -910 -340 -792 -633 -311 1,317 -478
Net Cash Flow 103 39 -52 24 -20 94 44 158 -113 72 73 230
Free Cash Flow -396 -393 -46 -84 233 782 984 1,044 252 785 439 925
CFO/OP 77% 108% 103% 83% 103% 100% 108% 87% 85% 100% 86% 92%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 43 36 38 37 39 33 46 44 49 48 51 50
Inventory Days 50 49 47 51 46 49 16 21 17 17 16 15
Days Payable 59 66 51 55 56 60 74 79 82 88 72 63
Cash Conversion Cycle 34 19 34 33 29 22 -12 -14 -16 -23 -6 3
Working Capital Days 24 16 27 8 -3 -8 -4 5 -1 -19 -6 -10
ROCE % 12% 9% 8% 7% 10% 14% 8% 17% 14% 15% 17% 18%

Insights

In beta
Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2025
Operating Beds
Number

Log in to view insights

Please log in to see hidden values.

Login
Pharmacy Store Count
Number
Average Length of Stay (ALOS)
Days
Average Revenue Per Occupied Bed (ARPOB/ARPP)
INR/Day
Bed Occupancy Rate
%
Inpatient Discharges
Number

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
29.33% 29.33% 29.33% 29.33% 29.33% 29.33% 29.33% 29.34% 29.34% 28.02% 28.02% 28.02%
47.93% 46.15% 46.25% 45.63% 43.92% 45.37% 45.27% 42.74% 43.49% 44.20% 43.54% 42.62%
17.02% 18.59% 18.87% 19.55% 21.13% 19.94% 19.97% 22.29% 21.34% 21.12% 21.50% 22.76%
0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23%
5.49% 5.68% 5.32% 5.26% 5.38% 5.12% 5.21% 5.41% 5.61% 6.43% 6.71% 6.39%
No. of Shareholders 1,20,0301,31,5651,19,5781,30,6641,27,7541,19,2451,27,8021,34,0581,41,0071,60,5561,78,6481,74,610

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls